Provectus Biopharmaceuticals, Inc.

PVCT ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
SCHEDULE 13D Dec 8, 2025
SCHEDULE 13D/A Dec 1, 2025
4 Nov 28, 2025
4 Nov 21, 2025 4
4 Nov 14, 2025 4
10-Q Nov 13, 2025 10-Q
4 Nov 7, 2025 4
4 Oct 31, 2025 4
4 Oct 24, 2025 4
4 Oct 17, 2025
4 Oct 14, 2025 4
4 Oct 9, 2025
4 Sep 30, 2025
4 Sep 19, 2025
4 Sep 19, 2025 4
4 Sep 12, 2025
4 Sep 5, 2025 4
4 Aug 29, 2025 4
4 Aug 27, 2025 4
4 Aug 22, 2025
10-Q Aug 14, 2025 10-Q
4 Aug 12, 2025 4
4 Jul 21, 2025
4 Jun 26, 2025
4 Jun 23, 2025
← Newer Page 3 of 43 · 1075 filings Older →